Title

WHO satellite on country experiences in monitoring new ARVs: Focus on toxicity monitoring and surveillance of dolutegravir during pregnancy to inform treatment policies

Code

FRSA06

Session Type

Non-Commercial Satellite

Venue

E102

Date Time

Friday 27 July, 07:00 - 08:30

Co-Chairs:

Meg Doherty, World Health Organization, Switzerland
Adele Benzaken, Ministry of Health, Brazil

Organizer:

WHO

The satellite will provide country examples and in depth discussion with panellists on how best to strengthen HIV patient monitoring and active toxicity monitoring as well as engage in epidemiological surveillance of ARV safety during pregnancy when introducing new ARVs. WHO global work on the safety review of neural tube defect signal with dolutegravir will be presented. Technical guidance and opportunities for pooling data under a global repository to analyse safety outcomes and inform treatment policies more rapidly will be discussed. This satellite will be of interest to programme managers, implementers, clinicians, civil society and researchers.

Presentations
Map

07:00 FRSA0601	Introductory remarks by Co-Chairs Meg Doherty, World Health Organization, Switzerland	Slides

07:05 FRSA0602	WHO Global work on safety review of neural tube defect signal and guidance on toxicity monitoring and pregnancy safety surveillance for dolutegravir Francoise Renaud, WHO, Switzerland	Slides

07:15 FRSA0603	Building a global approach: WHO global repository for epidemiological surveillance of drug safety in pregnancy and in general population Christine Halleux, WHO, Switzerland	Slides

07:20 FRSA0605	Birth outcomes surveillance programme in Botswana: The Tsepamo Study Rebecca Zash, Beth Israel Deaconess Medical Center, United States Modiegi Diseko, Ministry of Health, Malawi

07:30 FRSA0604	Brazil experience: Active toxicity monitoring in adults and birth defect surveillance with dolutegravir Adele Benzaken, Ministry of Health, Brazil	Slides

07:40 FRSA0606	Malawi experience: Person-centred HIV patient monitoring and birth defect surveillance programme Thokozani Kalua, Malawi	Slides

07:50 FRSA0607	Perspective from civil society: Taking into account and measuring HIV patient experience Solange Baptiste, International Treatment Preparedness Coalition, South Africa

08:00 FRSA0608	Q&A from the audience and their examples Adele Benzaken, Ministry of Health, Brazil Rebecca Zash, Beth Israel Deaconess Medical Center, United States Modiegi Diseko, Ministry of Health, Malawi Thokozani Kalua, Malawi Christine Halleux, WHO, Switzerland Heather Watts, Office of the Global AIDS Coordinator, US Department of State, United States Elliot Raizes, US Centers for Disease Control and Prevention, United States Solange Baptiste, International Treatment Preparedness Coalition, South Africa Francoise Renaud, WHO, Switzerland

08:25 FRSA0609	Closing remarks and next steps by Co-Chairs